Your browser doesn't support javascript.
Special Issue: Viral diseases and natural products: prospects in COVID-19 treatment (part IV). (Special Issue: Viral diseases and natural products: prospects in COVID-19 treatment (part IV).)
Current Pharmaceutical Design ; 27(33):3501-3589, 2021.
Article in English | CAB Abstracts | ID: covidwho-1716667
ABSTRACT
This special issue contains 5 articles that discuss dealing with natural products and viral diseases, focusing on the taxonomy, structure of SARS-CoV-2, history, transmission, epidemiology, pathology, clinical features and impacts of COVID-19, a review, based on the publicly available literature, of the knowledge regarding epidemiology, virology, diagnosis, clinical features, pharmacological and therapeutic ways to treat the novel coronavirus, the findings of the natural product-based anti-coronaviral research that has been published during the last two decades, and attempted to provide a comprehensive description of their utility as potential broad-spectrum anti-coronaviral drugs, thereby providing leads that may guide/facilitate anti-SARS-CoV-2 drug development studies, and seven known human strains of CoV were analyzed for the host and viral factors responsible for human outbreaks.
Keywords
Search on Google
Collection: Databases of international organizations Database: CAB Abstracts Language: English Journal: Current Pharmaceutical Design Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: Databases of international organizations Database: CAB Abstracts Language: English Journal: Current Pharmaceutical Design Year: 2021 Document Type: Article